Loading
PDBj
MenuPDBj@FacebookPDBj@TwitterPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

1W8C
DownloadVisualize
BU of 1w8c by Molmil
CO-CRYSTAL STRUCTURE OF 6-CYCLOHEXYLMETHOXY-8-ISOPROPYL-9H-PURIN-2- YLAMINE AND MONOMERIC CDK2
Descriptor: 6-(CYCLOHEXYLMETHOXY)-8-ISOPROPYL-9H-PURIN-2-AMINE, CELL DIVISION PROTEIN KINASE 2
Authors:Pratt, D.J, Endicott, J.A, Noble, M.E.M.
Deposit date:2004-09-20
Release date:2006-08-30
Last modified:2024-05-01
Method:X-RAY DIFFRACTION (2.05 Å)
Cite:8-Substituted O6-Cyclohexylmethylguanine Cdk2 Inhibitors; Using Structure-Based Inhibitor Design to Optimise an Alternative Binding Mode.
J.Med.Chem., 57, 2014
1VYZ
DownloadVisualize
BU of 1vyz by Molmil
Structure of CDK2 complexed with PNU-181227
Descriptor: CELL DIVISION PROTEIN KINASE 2, N-(5-CYCLOPROPYL-1H-PYRAZOL-3-YL)BENZAMIDE
Authors:Pevarello, P, Brasca, M.G, Amici, R, Orsini, P, Traquandi, G, Corti, L, Piutti, C, Sansonna, P, Villa, M, Pierce, B.S, Pulici, M, Giordano, G, Martina, K, Lfritzen, E, Nugent, R.A, Casale, E, Cameron, A, Ciomei, M, Roletto, F, Isacchi, A, Fogliatto, G, Pesenti, E, Pastori, W, Marsiglio, W, Leach, K.L, Clare, P.M, Fiorentini, F, Varasi, M, Vulpetti, A, Warpehoski, M.A.
Deposit date:2004-05-07
Release date:2004-06-17
Last modified:2024-05-08
Method:X-RAY DIFFRACTION (2.21 Å)
Cite:3-Aminopyrazole Inhibitors of Cdk2/Cyclin a as Antitumor Agents. 1. Lead Finding
J.Med.Chem., 47, 2004
1W5X
DownloadVisualize
BU of 1w5x by Molmil
HIV-1 protease in complex with fluoro substituted diol-based C2- symmetric inhibitor
Descriptor: (2R,3R,4R,5R)-2,5-BIS[(2,3-DIFLUOROBENZYL)OXY]-3,4-DIHYDROXY-N,N'-BIS[(1S,2R)-2-HYDROXY-2,3-DIHYDRO-1H-INDEN-1-YL]HEXAN EDIAMIDE, POL POLYPROTEIN
Authors:Lindberg, J, Pyring, D, Loewgren, S, Rosenquist, A, Zuccarello, G, Kvarnstroem, I, Zhang, H, Vrang, L, Claesson, B, Hallberg, A, Samuelsson, B, Unge, T.
Deposit date:2004-08-10
Release date:2004-12-22
Last modified:2024-05-08
Method:X-RAY DIFFRACTION (1.9 Å)
Cite:Symmetric Fluoro-Substituted Diol-Based HIV Protease Inhibitors. Ortho-Fluorinated and Meta-Fluorinated P1/P1'-Benzyloxy Side Groups Significantly Improve the Antiviral Activity and Preserve Binding Efficacy
Eur.J.Biochem., 271, 2004
3V04
DownloadVisualize
BU of 3v04 by Molmil
Discovery of Novel Allosteric MEK Inhibitors Possessing Classical and Non-classical Bidentate Ser212 Interactions.
Descriptor: 4-[(2-fluoro-4-iodophenyl)amino]-N-(2-hydroxyethoxy)-1H-indazole-5-carboxamide, ADENOSINE-5'-TRIPHOSPHATE, Dual specificity mitogen-activated protein kinase kinase 1, ...
Authors:Heald, R, Jackson, P, Savy, P, Jones, M, Gancia, E, Burton, B, Newman, R, Boggs, J, Chan, E, Chan, J, Choo, E, Merchant, M, Ultsch, M, Wiesmann, C, Belvin, M, Price, S.
Deposit date:2011-12-07
Release date:2012-05-09
Last modified:2023-09-13
Method:X-RAY DIFFRACTION (2.7 Å)
Cite:Discovery of Novel Allosteric Mitogen-Activated Protein Kinase Kinase (MEK) 1,2 Inhibitors Possessing Bidentate Ser212 Interactions.
J.Med.Chem., 55, 2012
3V6S
DownloadVisualize
BU of 3v6s by Molmil
Discovery of potent and selective covalent inhibitors of JNK
Descriptor: 3-{[4-(dimethylamino)butanoyl]amino}-N-(4-{[4-(pyridin-3-yl)pyrimidin-2-yl]amino}phenyl)benzamide, Mitogen-activated protein kinase 10
Authors:Park, H, Laughlin, J.D, LoGrasso, P.V.
Deposit date:2011-12-20
Release date:2012-02-01
Last modified:2012-07-25
Method:X-RAY DIFFRACTION (2.97 Å)
Cite:Discovery of potent and selective covalent inhibitors of JNK.
Chem.Biol., 19, 2012
1W0X
DownloadVisualize
BU of 1w0x by Molmil
Crystal structure of human CDK2 in complex with the inhibitor olomoucine.
Descriptor: CYCLIN-DEPENDENT KINASE 2, OLOMOUCINE
Authors:Schulze-Gahmen, U, Meijer, L, Kim, S.-H.
Deposit date:2004-06-14
Release date:2005-01-14
Last modified:2024-05-08
Method:X-RAY DIFFRACTION (2.2 Å)
Cite:Multiple Modes of Ligand Recognition: Crystal Structures of Cyclin-Dependent Protein Kinase 2 in Complex with ATP and Two Inhibitors, Olomoucine and Isopentenyladenine.
Proteins, 22, 1995
1W5V
DownloadVisualize
BU of 1w5v by Molmil
HIV-1 protease in complex with fluoro substituted diol-based C2- symmetric inhibitor
Descriptor: HIV-1 PROTEASE, N,N-[2,5-O-DI-3-FLUORO-BENZYL-GLUCARYL]-DI-[1-AMINO-INDAN-2-OL]
Authors:Lindberg, J, Pyring, D, Loewgren, S, Rosenquist, A, Zuccarello, G, Kvarnstroem, I, Zhang, H, Vrang, L, Claesson, B, Hallberg, A, Samuelsson, B, Unge, T.
Deposit date:2004-08-10
Release date:2004-12-01
Last modified:2024-05-08
Method:X-RAY DIFFRACTION (1.8 Å)
Cite:Symmetric Fluoro-Substituted Diol-Based HIV Protease Inhibitors. Ortho-Fluorinated and Meta-Fluorinated P1/P1'-Benzyloxy Side Groups Significantly Improve the Antiviral Activity and Preserve Binding Efficacy
Eur.J.Biochem., 271, 2004
1VVE
DownloadVisualize
BU of 1vve by Molmil
C-TERMINAL HALF OF VACCINIA VIRUS COMPLEMENT CONTROL PROTEIN, NMR, 21 STRUCTURES
Descriptor: VACCINIA VIRUS COMPLEMENT CONTROL PROTEIN
Authors:Wiles, A, Campbell, I.D, Barlow, P.N.
Deposit date:1997-06-25
Release date:1997-12-03
Last modified:2024-06-05
Method:SOLUTION NMR
Cite:NMR studies of a viral protein that mimics the regulators of complement activation.
J.Mol.Biol., 272, 1997
5AIK
DownloadVisualize
BU of 5aik by Molmil
Human DYRK1A in complex with LDN-211898
Descriptor: 4-(7-METHOXY-1-(TRIFLUOROMETHYL)-9H-PYRIDO[3,4-B]INDOL-9-yl)butan-1-amine, DYRK1A DUAL-SPECIFICITY TYROSINE-PHOSPHORYLATION REGULATED KINASE 1A, PHOSPHATE ION
Authors:Elkins, J.M, Soundararajan, M, Muniz, J.R.C, Cuny, G, Higgins, J, Edwards, A, Bountra, C, Knapp, S.
Deposit date:2015-02-15
Release date:2015-02-25
Last modified:2024-01-10
Method:X-RAY DIFFRACTION (2.7 Å)
Cite:Dyrk1A with Ldn-211898
To be published
1VVD
DownloadVisualize
BU of 1vvd by Molmil
C-TERMINAL HALF OF VACCINIA VIRUS COMPLEMENT CONTROL PROTEIN, NMR, 21 STRUCTURES
Descriptor: VACCINIA VIRUS COMPLEMENT CONTROL PROTEIN
Authors:Wiles, A, Campbell, I.D, Barlow, P.N.
Deposit date:1997-06-25
Release date:1997-12-03
Last modified:2024-06-05
Method:SOLUTION NMR
Cite:NMR studies of a viral protein that mimics the regulators of complement activation.
J.Mol.Biol., 272, 1997
5A54
DownloadVisualize
BU of 5a54 by Molmil
DYRK1A IN COMPLEX WITH NITRO BENZOTHIAZOLE FRAGMENT
Descriptor: DUAL SPECIFICITY TYROSINE-PHOSPHORYLATION-REGULATED KINASE 1A, N-(6-nitro-1,3-benzothiazol-2-yl)ethanamide
Authors:Rothweiler, U.
Deposit date:2015-06-16
Release date:2016-06-29
Last modified:2024-01-10
Method:X-RAY DIFFRACTION (2.63 Å)
Cite:Probing the ATP-Binding Pocket of Protein Kinase Dyrk1A with Benzothiazole Fragment Molecules
J.Med.Chem., 59, 2016
1WDY
DownloadVisualize
BU of 1wdy by Molmil
Crystal structure of ribonuclease
Descriptor: 2-5A-dependent ribonuclease, 5'-O-MONOPHOSPHORYLADENYLYL(2'->5')ADENYLYL(2'->5')ADENOSINE
Authors:Tanaka, N, Nakanishi, M, Kusakabe, Y, Goto, Y, Kitade, Y, Nakamura, K.T.
Deposit date:2004-05-19
Release date:2004-10-05
Last modified:2021-11-10
Method:X-RAY DIFFRACTION (1.8 Å)
Cite:Structural basis for recognition of 2',5'-linked oligoadenylates by human ribonuclease L
Embo J., 23, 2004
1WF5
DownloadVisualize
BU of 1wf5 by Molmil
Solution structure of the first Fn3 domain of Sidekick-2 protein
Descriptor: sidekick 2 protein
Authors:Qin, X, Hayashi, F, Yokoyama, S, RIKEN Structural Genomics/Proteomics Initiative (RSGI)
Deposit date:2004-05-26
Release date:2005-06-07
Last modified:2024-05-29
Method:SOLUTION NMR
Cite:Solution structure of the first Fn3 domain of Sidekick-2 protein
To be published
1WG0
DownloadVisualize
BU of 1wg0 by Molmil
Structural comparison of Nas6p protein structures in two different crystal forms
Descriptor: Probable 26S proteasome regulatory subunit p28
Authors:Nakamura, Y, Umehara, T, Tanaka, A, Horikoshi, M, Yokoyama, S, Padmanabhan, B, RIKEN Structural Genomics/Proteomics Initiative (RSGI)
Deposit date:2004-05-27
Release date:2005-06-07
Last modified:2023-10-25
Method:X-RAY DIFFRACTION (2.53 Å)
Cite:Structural comparison of Nas6p protein structures in two different crystal forms
To be Published
1WBT
DownloadVisualize
BU of 1wbt by Molmil
Identification of novel p38 alpha MAP Kinase inhibitors using fragment-based lead generation.
Descriptor: 3-FLUORO-5-MORPHOLIN-4-YL-N-[1-(2-PYRIDIN-4-YLETHYL)-1H-INDOL-6-YL]BENZAMIDE, MITOGEN-ACTIVATED PROTEIN KINASE 14
Authors:Tickle, J, Cleasby, A, Devine, L.A, Jhoti, H.
Deposit date:2004-11-05
Release date:2005-11-03
Last modified:2024-05-08
Method:X-RAY DIFFRACTION (2 Å)
Cite:Identification of Novel P38Alpha Map Kinase Inhibitors Using Fragment-Based Lead Generation.
J.Med.Chem., 48, 2005
1WIS
DownloadVisualize
BU of 1wis by Molmil
Solution structure of the fifth FNIII domain from human KIAA1514 protein
Descriptor: KIAA1514 protein
Authors:Suetake, T, Hayashi, F, Yokoyama, S, RIKEN Structural Genomics/Proteomics Initiative (RSGI)
Deposit date:2004-05-28
Release date:2005-07-19
Last modified:2024-05-29
Method:SOLUTION NMR
Cite:Solution structure of the fifth FNIII domain from human KIAA1514 protein
to be published
5A4Q
DownloadVisualize
BU of 5a4q by Molmil
DYRK1A IN COMPLEX WITH CHLORO BENZOTHIAZOLE FRAGMENT
Descriptor: DUAL SPECIFICITY TYROSINE-PHOSPHORYLATION-REGULATED KINASE 1A, N-(5-CHLORANYL-1,3-BENZOTHIAZOL-2-YL)ETHANAMIDE
Authors:Rothweiler, U.
Deposit date:2015-06-11
Release date:2016-06-29
Last modified:2024-01-10
Method:X-RAY DIFFRACTION (2.37 Å)
Cite:Probing the ATP-Binding Pocket of Protein Kinase Dyrk1A with Benzothiazole Fragment Molecules
J.Med.Chem., 59, 2016
3V8S
DownloadVisualize
BU of 3v8s by Molmil
Human RHO-ASSOCIATED PROTEIN KINASE 1 (ROCK 1) IN COMPLEX WITH INDAZOLE DERIVATIVE (COMPOUND 18)
Descriptor: 1-(1H-indazol-5-yl)-3-(2-phenylethyl)urea, Rho-associated protein kinase 1
Authors:Martin, M.P, Zhu, J.-Yi, Schonbrunn, E.
Deposit date:2011-12-23
Release date:2012-02-08
Last modified:2023-09-13
Method:X-RAY DIFFRACTION (2.286 Å)
Cite:Fragment-based and structure-guided discovery and optimization of rho kinase inhibitors.
J.Med.Chem., 55, 2012
5DI1
DownloadVisualize
BU of 5di1 by Molmil
MAP4K4 in complex with an inhibitor
Descriptor: 4-{6-amino-5-[4-(methylsulfonyl)phenyl]pyridin-3-yl}phenol, Mitogen-activated protein kinase kinase kinase kinase 4
Authors:Liu, S.
Deposit date:2015-08-31
Release date:2016-01-13
Last modified:2023-09-27
Method:X-RAY DIFFRACTION (2.9 Å)
Cite:Discovery of an in Vivo Tool to Establish Proof-of-Concept for MAP4K4-Based Antidiabetic Treatment.
Acs Med.Chem.Lett., 6, 2015
1WSG
DownloadVisualize
BU of 1wsg by Molmil
Co-crystal structure of E.coli RNase HI active site mutant (E48A/D134N*) with Mn2+
Descriptor: MANGANESE (II) ION, Ribonuclease HI
Authors:Tsunaka, Y, Takano, K, Matsumura, H, Yamagata, Y, Kanaya, S.
Deposit date:2004-11-05
Release date:2005-02-08
Last modified:2024-05-29
Method:X-RAY DIFFRACTION (2.2 Å)
Cite:Identification of Single Mn(2+) Binding Sites Required for Activation of the Mutant Proteins of E.coli RNase HI at Glu48 and/or Asp134 by X-ray Crystallography
J.Mol.Biol., 345, 2005
1WSD
DownloadVisualize
BU of 1wsd by Molmil
Alkaline M-protease form I crystal structure
Descriptor: CALCIUM ION, M-protease, SULFATE ION
Authors:Shirai, T, Suzuki, A, Yamane, T, Ashida, T, Kobayashi, T, Hitomi, J, Ito, S.
Deposit date:2004-11-05
Release date:2004-11-16
Last modified:2024-03-13
Method:X-RAY DIFFRACTION (1.5 Å)
Cite:High-resolution crystal structure of M-protease: phylogeny aided analysis of the high-alkaline adaptation mechanism
Protein Eng., 10, 1997
5CU2
DownloadVisualize
BU of 5cu2 by Molmil
Crystal structure of CK2alpha with 2-hydroxy-5-methylbenzoic acid and (methyl 4-((3-(3-chloro-4-(phenyl)benzylamino)propyl)amino)-4-oxobutanoat bound
Descriptor: 2-hydroxy-5-methylbenzoic acid, ACETATE ION, Casein kinase II subunit alpha, ...
Authors:Brear, P, De Fusco, C, Georgiou, K.H, Spring, D, Hyvonen, M.
Deposit date:2015-07-24
Release date:2016-11-30
Last modified:2024-01-10
Method:X-RAY DIFFRACTION (1.705 Å)
Cite:A fragment-based approach leading to the discovery of a novel binding site and the selective CK2 inhibitor CAM4066.
Bioorg. Med. Chem., 25, 2017
5CVH
DownloadVisualize
BU of 5cvh by Molmil
Crystal Structure of CK2alpha
Descriptor: ACETATE ION, ADENOSINE-5'-DIPHOSPHATE, Casein kinase II subunit alpha, ...
Authors:Brear, P, De Fusco, C, Georgiou, K.H, Spring, D, Hyvonen, M.
Deposit date:2015-07-26
Release date:2016-07-27
Last modified:2024-01-10
Method:X-RAY DIFFRACTION (1.848 Å)
Cite:Specific inhibition of CK2 alpha from an anchor outside the active site.
Chem Sci, 7, 2016
1WUA
DownloadVisualize
BU of 1wua by Molmil
The structure of Aplyronine A-actin complex
Descriptor: (8R,9R,10R,11R,14S,18S,20S,24S)-24-{(1R,2S,3R,6R,7R,8R,9S,10E)-8-(ACETYLOXY)-6-[(N,N-DIMETHYLALANYL)OXY]-11-[FORMYL(MET HYL)AMINO]-2-HYDROXY-1,3,7,9-TETRAMETHYLUNDEC-10-ENYL}-10-HYDROXY-14,20-DIMETHOXY-9,11,15,18-TETRAMETHYL-2-OXOOXACYCLOTE TRACOSA-3,5,15,21-TETRAEN-8-YL N,N,O-TRIMETHYLSERINATE, ADENOSINE-5'-TRIPHOSPHATE, Actin, ...
Authors:Hirata, K, Muraoka, S, Suenaga, K, Kuroda, T, Kato, K, Tanaka, H, Yamamoto, M, Takata, M, Yamada, K, Kigoshi, H.
Deposit date:2004-12-03
Release date:2006-02-14
Last modified:2023-10-25
Method:X-RAY DIFFRACTION (1.45 Å)
Cite:Structure basis for antitumor effect of aplyronine a
J.Mol.Biol., 356, 2006
1WWF
DownloadVisualize
BU of 1wwf by Molmil
NMR Structure Determined for MLV NC Complex with RNA Sequence CCUCCGU
Descriptor: 5'-R(P*CP*CP*UP*CP*CP*GP*U)-3', Nucleoprotein p10, ZINC ION
Authors:Dey, A, York, D, Smalls-Mantey, A, Summers, M.F.
Deposit date:2005-01-05
Release date:2005-04-05
Last modified:2024-05-01
Method:SOLUTION NMR
Cite:Composition and sequence-dependent binding of RNA to the nucleocapsid protein of Moloney murine leukemia virus(,)
Biochemistry, 44, 2005

224931

数据于2024-09-11公开中

PDB statisticsPDBj update infoContact PDBjnumon